ArticlePDF Available

Moderate Sedation or Monitored Anesthesia Care for Colonoscopies: Is There a Difference?

Authors:

Abstract and Figures

To determine whether monitored anesthesia care (MAC) results in shorter colonoscopy time. A retrospective chart review from electronic medical records at Sentara Norfolk General Hospital was performed of all patients seen by the Eastern Virginia Medical School Department of Surgery who underwent a screening or diagnostic colonoscopy from December 2015 to July 2017. The primary end point is procedure time, with secondary end point of sedation time. There is a statistically significant difference in time to cecum between moderate sedation (MOD) and MAC (P = 0.002). Operator perceived difficulty is statistically associated with increased time to cecum (P < 0.0001). Time to cecum between MOD and MAC over the levels of difficulty was not significant (P = 0.403). A subanalysis looking at time to cecum between MOD and MAC for each level of difficulty showed a significant effect when difficulty was described as no difficulty. There is a statistically significant difference in time to scope insertion between MOD and MAC (P < 0.0001). Our data show that, taken as a conglomerate, the procedure and sedation time is shorter in MAC than in MOD. The use of MAC is associated with decrease time to scope insertion and overall time to cecum.
Content may be subject to copyright.
Moderate Sedation or Monitored Anesthesia Care
for Colonoscopies: Is There a Difference?
MATTHEW NG, M.D., RAHIM DHANANI, M.S., HADIZA GALADIMA, PH.D., JESSICA BURGESS, M.D.
From the Eastern Virginia Medical School, Norfolk, Virginia
To determine whether monitored anesthesia care (MAC) results in shorter colonoscopy time. A
retrospective chart review from electronic medical records at Sentara Norfolk General Hospital
was performed of all patients seen by the Eastern Virginia Medical School Department of Surgery
who underwent a screening or diagnostic colonoscopy from December 2015 to July 2017. The
primary end point is procedure time, with secondary end point of sedation time. There is a sta-
tistically significant difference in time to cecum between moderate sedation (MOD) and MAC
(P50.002). Operator perceived difficulty is statistically associated with increased time to cecum
(P<0.0001). Time to cecum between MOD and MAC over the levels of difficulty was not sig-
nificant (P50.403). A subanalysis looking at time to cecum between MOD and MAC for each
level of difficulty showed a significant effect when difficulty was described as no difficulty. There
is a statistically significant difference in time to scope insertion between MOD and MAC (P<
0.0001). Our data show that, taken as a conglomerate, the procedure and sedation time is shorter in
MAC than in MOD. The use of MAC is associated with decrease time to scope insertion and
overall time to cecum.
THE UNITED STATES Preventative Task Force rec-
ommends screening for colorectal cancer with
colonoscopy, starting at the age of 50.
1
A colonoscopy
can be an uncomfortable experience for the patient.
Traditionally, a colonoscopy is performed with mod-
erate sedation (MOD), administered by the endo-
scopist. Recently, with the growing trend for a painless
procedure, monitored anesthesia care (MAC) has
been introduced. This entails an independent oper-
ator trained in anesthesia to provide sedation, at this
institution, propofol. The hypothesis queries whether
MAC provides a better procedure for the patient and
whether it is worth the extra costs.
Traditionally, MOD describes a state of conscious
sedation for the patient. It is a pharmacologic induced
depressed state in that the patient is still conscious, but
they are able to tolerate unpleasant stimuli. They are
able to respond to verbal or light tactile stimuli. The
patients continue to maintain their cardiovascular sta-
tus.
2
A common regimen is fentanyl and midazolam. A
bolus dose of fentanyl and midazolam is given and the
patient’s response is assessed in interval time.
3
Another form of sedation is MAC (also known as
deep sedation) which is commonly used in endoscopic
procedures. Propofol is routinely used and adminis-
tered by an anesthesia provider (certified registered
nurse anesthetist or anesthesiologist). The patients
continue to manage their own airway and respond to
repeated or painful stimuli. Similarly, they are able to
maintain their cardiovascular status.
4
At our institution, our surgeons perform colo-
noscopies using both types of sedation. Perceived
difficulty, prior colonoscopies, costs, and attending
preference drive decision-making for selecting se-
dation. This study aims to determine whether MAC
results in shorter procedure time.
Methods
A retrospective chart review from electronic medical
records at Sentara Norfolk General Hospital was per-
formed on all patients who underwent a screening or
diagnostic colonoscopy by the Eastern Virginia Med-
ical School Department of Surgery from December
2015 to July 2017. The primary end point is procedure
time, with the secondary end point being sedation time.
Data abstracted from chart reviews of patients who
underwent colonoscopy are the basis of this study. The
major variables being abstracted for this study are as
follows: age, time to cecum, difficulty of procedure as
documented by the surgeon (no difficulty, moderate
difficulty, and extremely difficult), and the American
Society of Anesthesiologist (ASA) score.
The inclusion criteria included patients aged 18 to
90 years undergoing screening or diagnostic colonos-
copy with an adequate bowel prep to evaluate for
Address correspondence and reprint requests to Matthew Ng,
M.D., Eastern Virginia Medical School, 825 Fairfax Avenue, 6th
Floor Norfolk, VA 23507. E-mail: ngm@evms.edu.
1284
polyps. These patients must have received either MOD
or MAC. Patients were excluded because of incom-
plete dictation.
Statistical Analysis
Patient demographics were summarized and tested
for differences between MOD and MAC using the ttest
for continuous variables after verifying normality of
data with the normal probability plot, and the chi-
square test for categorical variables. The normal data
were summarized as mean ± standard deviation and the
categorical variables as frequency (%). Differences
between MOD and MAC in terms of time to cecum and
time to scope insertion were tested using the non-
parametric Kruskal-Wallis test. A multiple linear re-
gression was used to assess the impact of ASA, body
mass index (BMI), and level of difficulty on time to
cecum. A two-way analysis of variance was used to
compare the time to cecum between MAC and MOD
over the levels of difficulty. All analyses were con-
ducted using SAS v9.4 (SAS Institute, Cary, NC). All
tests were considered statistically significant if the
Pvalue is less than 0.05. Statistics were provided by
the Eastern Virginia Medical School Center for Health
Analytics and Discovery.
Results
From December 2015 to July 2017, we identified
361 patients to be included in our study; 48 patients
were excluded. Of the 361 patients, 200 underwent
MAC and 161 had MOD. The characteristics of the
patients are identified in Table 1. The only signifi-
cant difference between the two groups is ASA
score. Patients undergoing MOD tended to have
lower ASA scores; ASA scores one (13 vs 1) and
two (130 vs 76), whereas higher scores for MAC,
ASA three (120 vs 18) and four (3 vs 0). There was
no difference in age (MAC: 57.91, MOD: 57.03),
BMI (MAC: 31.69, MOD: 30.56), gender (MAC:
female 114, male 86, MOD: female 78, male 83), or
perceived difficulty.
There is a statistically significant difference in time
to cecum between MOD and MAC (P40.002).
Median time for MAC is 17 minutes. It is statistically
lower than the median time in MOD of 21 minutes
(Table 2).
A subgroup analysis was performed to determine
whether ASA, BMI, or perceived level of difficulty
influenced time to cecum. Surgeon perceived diffi-
culty is statistically associated with a lower time to
cecum (P< 0.0001). ASA (P40.3515) and BMI
(P40.5029) did not affect time to cecum (Table 3).
As part of our standard documentation, surgeons
comment on their perceived difficulty of the proce-
dure. Using a numerical scale, 0 represents no diffi-
culty, 1 represents moderate difficulty, and 2 represents
extremely difficult. When colonoscopies were con-
sidered not difficult, the procedure time was statisti-
cally shorter for MAC (17 vs 21 minutes, P< 0.05).
TABLE 1. Patient Demographics
Demographic Characteristics MAC (n 4200) MOD (n 4161) PValue
Age (mean ± SD) 57.91 ± 9.34 57.03 ± 8.89 0.367
BMI (mean ± SD) 31.69 ± 8.68 30.56 ± 7.14 0.185
Gender
Female 114 (57%) 78 (48.45%) 0.1055
Male 86 (43%) 83 (51.55%)
ASA <0.0001
1 1 (0.5%) 13 (8.07%)
2 76 (38%) 130 (80.75%)
3 120 (60%) 18 (11.18%)
4 3 (1.5%) 0 (0%)
Difficulty 0.4479
0 144 (72%) 109 (67.7%)
1 33 (16.5%) 35 (21.74%)
2 23 (11.5%) 17 (10.56%)
SD 4standard deviation.
04perceived as no difficulty.
14perceived as some difficulty.
24perceived as extremely difficult.
TABLE 2. Time to Cecum between MOD and MAC
Variable MAC (n 4200) MOD (n 4161) Chi-Square Df PValue
Time to cecum, median (min – max) 17 (3–70) 21 (7–95) 14.08 1 0.0002
No. 8 MOD OR MAC FOR COLONOSCOPIES ?Ng et al. 1285
There is no statistically significant difference in time
to cecum between MAC and MOD when difficulty is
considered moderate or extremity difficult (Table 4).
There is a statistically significant difference in time to
scope insertion between MOD and MAC (2.95 vs 5
minutes, P< 0.0001). This is the time period between
when the procedural time-out is performed and when
the patient is considered adequately sedated and the
scope inserted (Table 5).
Discussion
Our data show that taken as a conglomerate, the
procedure and sedation time is faster in MAC than in
MOD. With the rising costs of health care, it is im-
portant to be cognizant of extra expenditures on pro-
cedures while maximizing patient safety. However,
when looking at the level of difficulty for the pro-
cedure, there was no difference in time for moderately
and extremely difficult procedures. MAC results in
faster colonoscopies and also decreases induction
time. Induction of propofol is faster than that of fen-
tanyl and versed to achieve a level of sedation suitable
for colonoscopy. Patients were also more deeply se-
dated with propofol.
5
Similar to the study conducted by Ulmer et al., MAC
resulted in shorter procedure times, although their
study only recruited patients with ASA score 1 or 2.
They noted that the overall procedure length including
time to discharge was on average 15 minutes shorter
than that in MOD.
5
Further investigation delineating between screening
and diagnostic colonoscopies is needed. Unsurpris-
ingly, the only predicting variable of procedure time is
difficulty score. At no difficulty, the MAC group was
quicker. As the procedure became more difficult, no
statistically significant difference was seen. Perhaps,
this is because of the patient already at such a deep
level of sedation on MAC or MOD to allow for the
more complex procedure. The weaknesses of the study
include a small sample size. Because the cohort is
small, it is difficult to conclude that the differences are
real. Another confounding variable is due to a variety
of different level residents performing the procedure
and it is difficult to ascertain their involvement.
We believe that our data are supportive of using
MAC for colonoscopies. It allows for a faster proce-
dure and provides another qualified health professional
administering sedation and monitoring airway so the
surgeon can focus solely on the procedure. Further
analysis is needed, including level resident involve-
ment, postprocedure recovery, patient satisfaction, and
costs.
REFERENCES
1. US Preventative Services Task Force. Screening for co-
lorectal cancer US Preventive Services Task Force recommenda-
tion statement. JAMA 2016;315:2564–75.
TABLE 3. ASA, BMI, and Level of Difficulty Influence Time to Cecum
Parameter Estimates
Variable Label Df Parameter Estimate Standard Error tValue PValue
Intercept Intercept 1 22.59012 2.93884 7.69 <0.0001
ASA ASA 1 –0.93244 0.99944 –0.93 0.3515
BMI BMI 1 –0.04759 0.07097 –0.67 0.5029
Difficulty Difficulty 1 7.73279 0.81754 9.46 <0.0001
TABLE 4. Time to Cecum Based on Perceived Difficulty Level
Time to Cecum between MAC and MOD across Difficulty Levels
Difficulty 40 Difficulty 41 Difficulty 42
Sedation Mean PValue Mean PValue Mean PValue
MAC 17.299 0.0012 24.788 0.8238 32.565 0.0714
MOD 21.431 25.371 39.824
Difference (MAC – MOD) –4.133 –0.584 –7.258
TABLE 5. Time of Sedation before Procedure Starts
Variable MAC (n 4200) MOD (n 4161) Chi-Square Df PValue
Time to scope insertion 2.95 (1–14.82) 5 (0–26.77) 119.46 1 <0.0001
THE AMERICAN SURGEON August 20181286 Vol. 84
2. Waring JP, Baron TH, Hirota WK, et al. Guidelines for
conscious sedation and monitoring during gastrointestinal endos-
copy. Gastrointest Endosc 2003;58:317–22.
3. McQuaid KR, Laine L. A systematic review and meta-
analysis of randomized, controlled trials of moderate sedation for
routine endoscopic procedures. Gastrointest Endosc 2008;67:
910–23.
4. Faigel DO, Baron TH, Goldstein JL, et al. Guidelines for the
use of deep sedation and anesthesia for GI endoscopy. Gastrointest
Endosc 2002;56:613–7.
5. Ulmer BJ, Hansen JJ, Overley CA, et al. Propofol versus
midazolam/fentanyl for outpatient colonoscopy: administration by
nurses supervised by endoscopists. Clin Castroenterol Hepatol
2003;1:425–32.
No. 8 MOD OR MAC FOR COLONOSCOPIES ?Ng et al. 1287
... The administration of MAC was performed by a certified registered nurse anesthetist or an anesthesiologist. 22 The patients maintained their own airway and cardiovascular status. 23 For patients with a predicted gastric fluid volume exceeding 100 mL, complete suctioning of the esophagus and stomach through gastroscopy was performed before examining the gastrointestinal tract with MAC. ...
Article
Full-text available
Purpose In this prospective observational study, an ultrasonographic measurement of antral cross-sectional area (ACSA) was conducted to evaluate the gastric content and volume as well as to identify high-risk stomach in non-pregnant adult surgical patients adhering to preanesthetic fasting guidelines. Patients and Methods Fasted patients undergoing gastrointestinal endoscopy under sedation were included. Ultrasonographic measurements of ACSA were conducted in both semi-recumbent and right lateral decubitus positions before endoscopic procedures. Gastroscopy was employed to guide the measurement of suctioned gastric volume (GV). Ultrasonography was performed to assess gastric contents and identify patients with high-risk stomach. The relationship between ACSA and suctioned GV was also evaluated. Results ACSA was evaluated in 736 out of 782 patients. A significant positive correlation was discovered between ACSA in the right lateral decubitus position and suctioned GV, which was more reliable than in the semi-recumbent position. To analyze high-risk stomach with a GV > 100 mL, the cutoff value of ACSA in the right lateral decubitus was found to be 7.5 cm², with the AUC, sensitivity and specificity of 0.80 (95% CI, 0.76–0.82; P<0.001), 82.4% and 67.3%, respectively. A novel mathematical model based on ACSA to estimate GV in non-pregnant fasted adults was presented. Conclusion Ultrasonographic measurement of ACSA can assist anesthesiologists in estimating the risk of pulmonary aspiration of gastric contents during general anesthesia and sedation.
... We carefully administer sedation in elderly patients, generally with reduced starting doses and smaller and less frequent incremental doses to decrease the risk of cardiopulmonary complications, in accordance with ASGE recommendations [12]. Monitored anesthesia care (MAC) using propofol has been shown to decrease procedural time and risk of cardiopulmonary complications in multiple studies and has been shown to be safe in elderly patients [55][56][57][58][59]. Moderate sedation with the use of intravenous benzodiazepines and opiates has not been well studied in the elderly, although it has been shown that reduced doses are necessary in this population [60,61]. ...
Article
Full-text available
Purpose of review As the average life expectancy rises in the USA, an increasing number of elderly patients are being referred for both screening and diagnostic colonoscopy. In this article, we review recent data and propose an approach to the consideration of polypectomy in elderly patients. Recent findings Current data highlight the importance of considering age, medical comorbidities, functional status, and pre-operative planning to identify patients most likely to benefit from colonoscopy and polypectomy. Cold snare polypectomy and cold endoscopic mucosal resection, in addition to the use of prophylactic hemostatic clips for large, proximal polyps, reduce post-polypectomy bleeding risk. Post-procedurally, elderly patients should be informed to monitor for specific signs and symptoms of adverse events. Summary The decision to perform polypectomy in elderly patients should be individualized and involve clear, informed shared decision-making. Specific approaches can be taken to decrease risk of adverse events in elderly patients. Additional research is needed to establish clearer guidelines in this population.
Article
Background and aims: Nearly all routine endoscopy procedures are performed using moderate sedation (MS) or monitored anesthesia care (MAC). In this article, we describe how we improved decision-making and decreased practitioners' cognitive burden for choosing between MAC and MS by utilizing patient data in an automated application within the electronic health record (EHR). Methods: In our practice, we choose between MS or MAC for routine gastrointestinal (GI) procedures according to written anesthesia use guidelines and practitioner preferences. To expedite our decision-making for MS vs MAC, we developed an Excel-based tool from patient demographic characteristics, comorbid conditions, and medication use extracted from the EHR. The data points from Excel were then implemented in the automated application in the EHR to predict the type of sedation for GI procedures. Results: Before use of the new application, nurses spent an average of 4 minutes and gastroenterology practitioners spent 5 minutes reviewing the EHR to determine the appropriate sedation (MS or MAC). After the application was implemented, the use of MS substantially increased. Time spent reviewing the EHR was reduced to 2 minutes. The rate of adverse events for MS (0.5%) vs MAC (0.6%) was comparable and low overall. Conclusions: The EHR-based application, which automates and standardizes determination of sedation type, is a highly beneficial tool that eliminates subjectivity in decision-making, thus allowing for appropriate use of MAC. Complication rates and sedation failure did not increase with use of the application. With the increase in use of MS over MAC, health care costs for the more expensive MAC sedation should also decrease.
Article
Importance Colorectal cancer is the second leading cause of cancer death in the United States. In 2016, an estimated 134 000 persons will be diagnosed with the disease, and about 49 000 will die from it. Colorectal cancer is most frequently diagnosed among adults aged 65 to 74 years; the median age at death from colorectal cancer is 68 years. Objective To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for colorectal cancer. Evidence Review The USPSTF reviewed the evidence on the effectiveness of screening with colonoscopy, flexible sigmoidoscopy, computed tomography colonography, the guaiac-based fecal occult blood test, the fecal immunochemical test, the multitargeted stool DNA test, and the methylated SEPT9 DNA test in reducing the incidence of and mortality from colorectal cancer or all-cause mortality; the harms of these screening tests; and the test performance characteristics of these tests for detecting adenomatous polyps, advanced adenomas based on size, or both, as well as colorectal cancer. The USPSTF also commissioned a comparative modeling study to provide information on optimal starting and stopping ages and screening intervals across the different available screening methods. Findings The USPSTF concludes with high certainty that screening for colorectal cancer in average-risk, asymptomatic adults aged 50 to 75 years is of substantial net benefit. Multiple screening strategies are available to choose from, with different levels of evidence to support their effectiveness, as well as unique advantages and limitations, although there are no empirical data to demonstrate that any of the reviewed strategies provide a greater net benefit. Screening for colorectal cancer is a substantially underused preventive health strategy in the United States. Conclusions and Recommendations The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years (A recommendation). The decision to screen for colorectal cancer in adults aged 76 to 85 years should be an individual one, taking into account the patient’s overall health and prior screening history (C recommendation).
Article
This is one of a series of statements discussing the utilization of gastrointestinal endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy prepared this text. In preparing this guideline, a MEDLINE literature search was performed, and additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When little or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate utilization of endoscopy are based on a critical review of the available data and expert consensus. Further controlled clinical studies are needed to clarify aspects of this statement, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations.
Article
This is one of a series of statements discussing the utilization of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy prepared this text. In preparing this guideline, a MEDLINE literature search was performed, and additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When little or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate utilization of endoscopy are based on a critical review of the available data and expert consensus. Further controlled clinical studies are needed to clarify aspects of this statement, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations.
Article
Numerous agents are available for moderate sedation in endoscopy. Our purpose was to compare efficacy, safety, and efficiency of agents used for moderate sedation in EGD or colonoscopy. Systematic review of computerized bibliographic databases for randomized trials of moderate sedation that compared 2 active regimens or 1 active regimen with placebo or no sedation. Unselected adults undergoing EGD or colonoscopy with a goal of moderate sedation. Sedation-related complications, patient assessments (satisfaction, pain, memory, willingness to repeat examination), physician assessments (satisfaction, level of sedation, patient cooperation, examination quality), and procedure-related efficiency outcomes (sedation, procedure, or recovery time). Thirty-six studies (N = 3918 patients) were included. Sedation improved patient satisfaction (relative risk [RR] = 2.29, range 1.16-4.53) and willingness to repeat EGD (RR = 1.25, range 1.13-1.38) versus no sedation. Midazolam provided superior patient satisfaction to diazepam (RR = 1.18, range 1.07-1.29) and less frequent memory of EGD (RR = 0.57, range 0.50-0.60) versus diazepam. Adverse events and patient/physician assessments were not significantly different for midazolam (with or without narcotics) versus propofol except for slightly less patient satisfaction (RR = 0.90, range 0.83-0.97) and more frequent memory (RR = 3.00, range 1.25-7.21) with midazolam plus narcotics. Procedure times were similar, but sedation and recovery times were shorter with propofol than midazolam-based regimens. Marked variability in design, regimens tested, and outcomes assessed; relatively poor methodologic quality (Jadad score </=3 in 23/36 trials). Moderate sedation provides a high level of physician and patient satisfaction and a low risk of serious adverse events with all currently available agents. Midazolam-based regimens have longer sedation and recovery times than does propofol.
Article
Propofol is under evaluation as a sedative for endoscopic procedures. We compared nurse-administered propofol to midazolam plus fentanyl for outpatient colonoscopy. One hundred outpatients undergoing colonoscopy were randomized to receive propofol or midazolam plus fentanyl, administered by a registered nurse and supervised only by an endoscopist. Endpoints were patient satisfaction, procedure and recovery times, neuropsychologic function, and complications. The mean dose of propofol administered was 277 mg; mean doses of midazolam and fentanyl were 7.2 mg and 117 microg, respectively. Mean time to sedation was faster with propofol (2.1 vs. 6.1 min; P<0.0001), and depth of sedation was greater (P<0.0001). Patients receiving propofol reached full recovery sooner (16.5 vs. 27.5 min; P=0.0001) and were discharged sooner (36.5 vs. 46.1 min; P=0.01). After recovery, the propofol group scored better on tests reflective of learning, memory, working memory span, and mental speed. Six minor complications occurred in the propofol group: 4 episodes of hypotension, 1 episode of bradycardia, and 1 rash. Five complications occurred with the use of midazolam and fentanyl: one episode of oxygen desaturation requiring mask ventilation and 4 episodes of hypotension. Patients in the propofol vs. midazolam and fentanyl groups reported similar degrees of overall satisfaction using a 10-cm visual analog scale (9.3 vs. 9.4, P>0.5). Nurse-administered propofol resulted in several advantages for outpatient colonoscopy compared with midazolam plus fentanyl, but did not improve patient satisfaction.
US Preventative Services Task Force. Screening for colorectal cancer US Preventive Services Task Force recommendation statement
US Preventative Services Task Force. Screening for colorectal cancer US Preventive Services Task Force recommendation statement. JAMA 2016;315:2564-75.